《中国药典》植物类中药材基原问题探讨

Overview of the Plant Origins of Chinese Medicinal Materials in Chinese Pharmacopoeia

关键词:  中国药典  中药材  植物基原  药材来源  质量标准

Key words:  the Chinese Pharmacopoeia  Chinese medicinal materials  original plants  the resources of Chinese medicinal materials  quality standards

摘要:

目的 为进一步完善《中国药典》中药材质量标准，让学界和业界了解《中国药典》中药材基原修订的基本思路和目前尚需修订的品种状况，同时也为2030年版《中国药典》中药材基原修订提供参考。方法 对2025年版《中国药典》收载的植物类中药材基原的科属种名称与《中国植物志》和Flora of China等植物分类学著作及文献进行查询和考证，并对《中国药典》2010年版以来中药材基原修订内容及其依据进行剖析，还就学界和业界关注的有关中药材基原问题进行探讨。结果 《中国药典》收载的部分植物基原的中文名称和拉丁学名与植物分类权威著作存在着差别，个别甚至存在错误，《中国药典》2010年版以来对中药材基原的修订是合理的，但尚存在其他问题待修订。结论 《中国药典》中药材基原仍需修订，本文并提出了具体问题的修订建议。

Abstract:

OBJECTIVE In order to further improve the quality standards of Chinese medicinal materials in the Chinese Pharmacopoeia , and to let the academia and industry understand the basic principles of the revision. It also provides a reference for the revision of the origins of Chinese medicinal materials in the Chinese Pharmacopoeia 2030 edition. METHODS Query for the names of the family, genus, species of the Chinese medicinal materials original plants in the Chinese Pharmacopoeia 2025 edition and those such taxonomic literature as Flora of China (the Chinese version and the English version) as well as related references， and make textual research for the problems found. Also analyse the revision and its justifications on the origins of Chinese medicinal materials in Chinese Pharmacopoeia since the 2010 edition. Further more, discuss the issues related to the origins of Chinese medicinal materials that are of concern to the academic and industry. RESULTS There are some differences in Chinese names, Latin scientific names of some plant origins between the Chinese Pharmacopoeia and those in authoritative taxonomic literature, and even there are some errors in the Chinese Pharmacopoeia. The revision of the plant origins of Chinese medicinal materials in the Chinese Pharmacopoeia since sine 2010 edition is reasonable, but there are also other problems existing yet. CONCLUSION The plant origins of Chinese medicinal materials in the Chinese Pharmacopoeia still need to be revised. Further the paper puts forward specific revision suggestions to solve problems.